[1]皮祖骞.连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效[J].医学信息,2023,36(10):154-157.[doi:10.3969/j.issn.1006-1959.2023.10.034]
　PI Zu-qian.Clinical Effect of Lianhua Qingwen Granules Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Journal of Medical Information,2023,36(10):154-157.[doi:10.3969/j.issn.1006-1959.2023.10.034]
点击复制

连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年10期
页码:
154-157
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Clinical Effect of Lianhua Qingwen Granules Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children
文章编号:
1006-1959（2023）10-0154-04
作者:
皮祖骞
（上栗县中医院公共卫生科，江西 上栗 337009）
Author(s):
PI Zu-qian
(Public Health Department of Shangli County Traditional Chinese Medicine Hospital,Shangli 337009,Jiangxi,China)
关键词:
小儿肺炎支原体肺炎; 阿奇霉素; 连花清瘟颗粒; 肺功能; 炎性因子
Keywords:
Mycoplasma pneumoniae pneumonia in children; Azithromycin; Lianhua Qingwen granules; Pulmonary function; Inflammatory factors
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2023.10.034
文献标志码:
A
摘要:
目的 研究连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎（MPP）的临床疗效。方法 选取2020年12月-2021年12月上栗县中医院收治的82例MPP患儿为研究对象，采用随机数字表法分为对照组（41例）与观察组（41例），对照组采用阿奇霉素治疗，观察组给予连花清瘟颗粒联合阿奇霉素治疗，比较两组临床疗效、中医症状积分、症状消退时间（退热时间、咳嗽消失时间、气促消失时间、肺部啰音消失时间）、肺功能[第1 s用力呼气容积（FEV1）、用力肺活量（FVC）、FEV1/FVC]、血清炎性指标[白细胞介素-6（IL-6）、超敏C反应蛋白（hs-CRP）]及不良反应。结果 观察组总有效率高于对照组（P＜0.05）；两组治疗后中医症状积分低于治疗前，且观察组低于对照组（P＜0.05）；观察组退热时间、气促消失时间、咳嗽消失时间、肺部啰音消失时间均短于对照组（P＜0.05）；观察组FEV1、FVC、FEV1/FVC高于对照组（P＜0.05）；观察组IL-6、hs-CRP水平低于对照组（P＜0.05）；观察组不良反应发生率小于对照组（P＜0.05）。结论 连花清瘟颗粒联合阿奇霉素治疗MPP疗效肯定，可快速缓解患儿症状，改善患儿肺功能，降低炎性反应，不良反应少，安全性良好。
Abstract:
Objective To study the clinical efficacy of Lianhua Qingwen granules combined with azithromycin in treatment of mycoplasma pneumoniae pneumonia (MPP) in children.Methods A total of 82 children with MPP admitted to Shangli County Hospital of Traditional Chinese Medicine from December 2020 to December 2021 were selected as the research objects. They were divided into control group (41 patients) and observation group (41 patients) by random number table method. The control group was treated with azithromycin, and the observation group was treated with Lianhua Qingwen Granules combined with azithromycin. The clinical efficacy, TCM symptom score, symptom regression time (antipyretic time, cough disappearance time, shortness of breath disappearance time, lung rale disappearance time), lung function [forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), FEV1/FVC], serum inflammatory indicators [interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP)] and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group (P<0.05). After treatment, the scores of TCM symptoms in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P<0.05). The antipyretic time, shortness of breath disappearance time, cough disappearance time and lung rale disappearance time in the observation group were shorter than those in the control group (P<0.05). FEV1, FVC and FEV1/FVC in the observation group were higher than those in the control group (P<0.05). The levels of IL-6 and hs-CRP in the observation group were lower than those in the control group (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05).Conclusion Lianhua Qingwen granule combined with azithromycin is effective in the treatment of MPP, which can quickly relieve the symptoms of children, improve the lung function, reduce the inflammatory reaction, and have fewer adverse reactions and good safety.

参考文献/References:

[1]Krafft C,Christy C.Mycoplasma Pneumonia in Children and Adolescents[J].Pediatrics in Review,2020,41(1):12-19.[2]姜之炎,王雪峰,王力宁,等.小儿肺炎支原体肺炎多中心流行性特征分析[J].中华中医药杂志,2018,33(1):376-379.[3]林巧楠,周鹏翔,翟所迪,等.注射用阿奇霉素治疗小儿支原体肺炎疗效与安全性的系统评价[J].中国药房,2018,29(22):3146-3152.[4]Wang M,Li H,Yang J,et al.Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children: A protocol of randomized controlled trial[J].Medicine,2021,100(12):e25135.[5]刘颖,门鹏,张妍,等.连花清瘟胶囊治疗呼吸系统感染的循证评价[J].中国药学杂志,2020,55(19):1639-1643.[6]蔡露良,林涛,钟广会,等.连花清瘟颗粒联合泛福舒治疗0～5岁儿童反复呼吸道感染的疗效及对炎性因子的影响[J].中华中医药学刊,2020,38(8):195-199.[7]Zhai YY,Wu SZ,Yang Y,et al.An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children[J].Annals of Palliative Medicine,2020,9(5):361-362.[8]曹迎春.阿奇霉素治疗小儿支原体肺炎的临床疗效及不良反应情况观察[J].中国药物与临床,2020,20(23):3969-3971.[9]Han R,Yu Q,Zhang G,et al.Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children[J].Pakistan Journal of Medical Sciences,2020,36(2):156-159.[10]Wang X,He H,Zheng J,et al.A comparison of efficacy and safety of complementary and alternative therapies for severe mycoplasma pneumonia in children: A protocol for systematic review and meta-analysis[J].Medicine,2021,100(7):e23959.[11]吕伟刚,张岩,宋桂华,等.千金苇茎汤加减方联合阿奇霉素治疗痰热壅肺兼血瘀证小儿肺炎支原体肺炎随机对照研究[J].中国中西医结合杂志,2021,41(10):1192-1196.[12]戚畅,刘炘.中药方剂联合阿奇霉素抗支原体感染对小儿支原体肺炎的临床疗效分析[J].中国中医基础医学杂志,2017,23(11):1590-1592.[13]陈团营,朱珊,边红恩,等.连花清瘟颗粒对小儿肺炎支原体肺炎肺功能指标、血清炎症因子水平影响及疗效分析[J].中华中医药学刊,2018,36(11):2713-2715.[14]张建文,项李娥,桂金贵,等.桑菊饮加减联合阿奇霉素治疗小儿肺炎支原体感染风热咳嗽临床观察[J].安徽中医药大学学报,2018,37(5):19-21.[15]张帆,高金星.热毒宁联合阿奇霉素治疗小儿肺炎支原体肺炎的有效性及安全性[J].医学综述,2018,24(17):3533-3537.[16]阿爽,马少春,常红.复方甘草酸苷联合阿奇霉素治疗小儿肺炎支原体肺炎的疗效及安全性评价[J].中国医院药学杂志,2019,39(1):76-80.[17]张磊,韩丽.连花清瘟颗粒联合哌拉西林舒巴坦治疗肺炎的临床观察[J].现代药物与临床,2018,33(8):1960-1963.[18]陈芸,韩长青,赵凤兰,等.连花清瘟颗粒联合阿奇霉素治疗小儿肺炎支原体肺炎的临床观察[J].世界中医药,2020,15(1):76-80.[19]徐国防,高盼,刘平,等.连花清瘟胶囊联合阿奇霉素治疗肺炎支原体肺炎的临床疗效及对免疫功能的影响[J].药物评价研究,2020,43(11):2241-2244.[20]胡利军,李胖.痰热清联合阿奇霉素序贯疗法治疗小儿肺炎支原体肺炎的效果分析[J].辽宁中医杂志,2017,44(7):1442-1444.[21]王妍,彭经纬,覃涛.连花清瘟颗粒对儿童肺炎支原体肺炎肺功能及炎性因子的影响[J].儿科药学杂志,2019,25(4):35-37.[22]Yang HJ,Song DJ,Shim JY.Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children[J].Korean Journal of Pediatrics,2017,60(6):167-174.[23]林泉,缪长新,魏旭华,等.连花清瘟颗粒联合阿奇霉素序贯治疗儿童肺炎支原体肺炎合并肺不张疗效及对T淋巴细胞亚群和炎性因子的影响[J].现代中西医结合杂志,2019,28(2):153-158.

相似文献/References:

[1]赵俊芝,赵永强,梁 曼.甲泼尼龙联合阿奇霉素治疗难治性支原体肺炎患儿的 临床效果分析[J].医学信息,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
　ZHAO Jun-zhi,ZHAO Yong-qiang,LIANG Man.Analysis of the Clinical Effect of Methylprednisolone Combined with Azithromycin in Treatment of Children with Refractory Mycoplasma Pneumonia[J].Journal of Medical Information,2018,31(10):131.[doi:10.3969/j.issn.1006-1959.2018.07.044]
[2]冯瑞丰.阿奇霉素治疗急性细菌性下呼吸道感染的 有效性和安全性评价[J].医学信息,2019,32(11):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
　FENG Rui-feng.Evaluation of the Efficacy and Safety of Azithromycin in the Treatment of Acute Bacterial Lower Respiratory Tract Infections[J].Journal of Medical Information,2019,32(10):152.[doi:10.3969/j.issn.1006-1959.2019.11.045]
[3]陈艳丽.甲泼尼龙联合阿奇霉素治疗小儿难治性支原体肺炎的疗效与安全性的Meta分析[J].医学信息,2020,33(06):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
　CHEN Yan-li.Meta-analysis of the Efficacy and Safety of Methylprednisolone Combined with Azithromycin in the Treatment of Refractory Mycoplasmal Pneumonia in Children[J].Journal of Medical Information,2020,33(10):96.[doi:10.3969/j.issn.1006-1959.2020.06.028]
[4]刘金虹.阿奇霉素用于儿科抗感染的不良反应分析[J].医学信息,2020,33(16):161.[doi:10.3969/j.issn.1006-1959.2020.16.052]
　LIU Jin-hong.Analysis of Adverse Reaction of Azithromycin in Pediatric Anti-infection[J].Journal of Medical Information,2020,33(10):161.[doi:10.3969/j.issn.1006-1959.2020.16.052]
[5]张舒扬.阿奇霉素联合头孢地嗪对急性细菌性痢疾患儿白细胞计数及C-反应蛋白水平的影响[J].医学信息,2022,35(06):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
　ZHANG Shu-yang.Effect of Azithromycin Combined with Cefodizime on White Blood Cell Count and C-reactive Protein Level in Children with Acute Bacillary Dysentery[J].Journal of Medical Information,2022,35(10):165.[doi:10.3969/j.issn.1006-1959.2022.06.043]
[6]吴建伟.阿奇霉素联合头孢类药物在慢性阻塞性肺疾病急性加重期抗感染治疗中的疗效[J].医学信息,2022,35(13):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
　WU Jian-wei.Effect of Azithromycin Combined with Cephalosporins in Anti-infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(10):127.[doi:10.3969/j.issn.1006-1959.2022.13.029]
[7]温 鑫,邓 春.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎支原体肺炎的疗效评价[J].医学信息,2023,36(06):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
　WEN Xin,DENG Chun.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Mycoplasma Pneumoniae Pneumonia in Children[J].Journal of Medical Information,2023,36(10):147.[doi:10.3969/j.issn.1006-1959.2023.06.032]
[8]郭志丽,刘改莲,贺 蓉.阿奇霉素、氨溴特罗联合肺力咳合剂对支原体感染患儿血常规及CRP水平的影响[J].医学信息,2023,36(09):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
　GUO Zhi-li,LIU Gai-lian,HE Rong.Effect of Azithromycin, Ambroxol Combined with Feilike Mixture on Blood Routine and CRP Level in Children with Mycoplasma Infection[J].Journal of Medical Information,2023,36(10):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
[9]章云云.美洛西林联合阿奇霉素治疗小儿肺炎链球菌肺炎的临床效果[J].医学信息,2023,36(13):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]
　ZHANG Yun-yun.Clinical Effect of Mezlocillin Combined with Azithromycin in the Treatment of Children with Streptococcus Pneumoniae Pneumonia[J].Journal of Medical Information,2023,36(10):131.[doi:10.3969/j.issn.1006-1959.2023.13.027]
[10]杨芬香.盐酸氨溴索辅佐阿奇霉素治疗儿童肺炎、支气管炎的疗效评价[J].医学信息,2023,36(13):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]
　YANG Fen-xiang.Efficacy Evaluation of Ambroxol Hydrochloride Combined with Azithromycin in the Treatment of Pneumonia and Bronchitis in Children[J].Journal of Medical Information,2023,36(10):144.[doi:10.3969/j.issn.1006-1959.2023.13.031]

更新日期/Last Update: 1900-01-01